tetano
Editor, Senior Moderator
Drug Discov Ther. 2020;14(1):58-60. doi: 10.5582/ddt.2020.01012. [h=1]Discovering drugs to treat coronavirus disease 2019 (COVID-19).[/h]
Dong L[SUP]1[/SUP], Hu S[SUP]2[/SUP], Gao J[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.
[h=4]KEYWORDS:[/h] 2019-nCoV; COVID-19; SARS-CoV-2; novel coronavirus; pneumonia
PMID: 32147628 DOI: 10.5582/ddt.2020.01012
Free full text
Dong L[SUP]1[/SUP], Hu S[SUP]2[/SUP], Gao J[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals specific to the virus. Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (COVID-19) in China; some promising results have been achieved thus far. This article summarizes agents with potential efficacy against SARS-CoV-2.
[h=4]KEYWORDS:[/h] 2019-nCoV; COVID-19; SARS-CoV-2; novel coronavirus; pneumonia
PMID: 32147628 DOI: 10.5582/ddt.2020.01012
Free full text